Ars Pharmaceuticals Inc SPRY
Super Investor & Insider
1
Fondi che lo detengono
#1090
Rank consenso
1.4%
% dei portafogli
$8.0M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Daniel Loeb · Third Point | 0.39% | Add 79.78% | 1,000,000 | $8.0M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ars Pharmaceuticals Inc. specializes in the biopharmaceutical sector, focusing on the development of innovative, self-administered therapeutics aimed at improving patient outcomes. The company's primary purpose is to advance medical solutions for allergy-related indications, enhancing safety and convenience for patient…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees154
TickerSPRY
Statistics
Market Cap$983.1M
Revenue (TTM)$84.3M
Net Income-$171.3M
Net Margin-203.3%
EPS$-1.74
P/E168.25
P/S9.29
P/B8.05
EV/EBITDA-4.43
ROE-136.4%
Dividend Yield—
Price$9.90
Data: Twelve Data · Revenue = mcap / P/S